David joined Seagen as Chief Executive Officer and a member of the Board of Directors in 2022, bringing more than 30 years of drug development, deal making, commercialization and people leadership experience on a global scale. During his tenure, Seagen’s portfolio of innovative cancer medicines has grown significantly, and he prioritized its research and development focus and plans for continued growth, including an expanded presence globally.
Prior to Seagen, David was executive partner at Flagship Pioneering, a developer of bioplatform companies. From early-2010 to mid-2016, he served as chief executive officer of Novartis Pharmaceuticals, a division of Novartis AG. Previously, David started and led Novartis’ Oncology and Molecular Diagnostic units. Under his leadership the company’s oncology business grew to the second largest in the world. He’s led the development and commercialization of over 30 new molecular entities, including major breakthroughs such as Glivec, Tasigna, Gilenya, Afinitor, Cosentyx and Entresto. He was also recognized by FierceBiotech as one of the “25 most influential people in biopharma.”
David holds a B.S. Degree in Pharmacy from Rutgers University College of Pharmacy (1984) and an MBA in Finance and Marketing from the Columbia University Graduate School of Business (1987). He serves as a board member at Valo Health, a company using technology to reimagine drug discovery and development, and Opy Acquisition Corp, a life sciences investment company.
What is David R. Epstein's net worth?
The estimated net worth of David R. Epstein is at least $31.25 million as of November 10th, 2023. Mr. Epstein owns 136,598 shares of Seagen stock worth more than $31,245,427 as of April 27th. This net worth evaluation does not reflect any other assets that Mr. Epstein may own. Additionally, Mr. Epstein receives an annual salary of $1,390,000.00 as CEO at Seagen. Learn More about David R. Epstein's net worth.
How old is David R. Epstein?
Mr. Epstein is currently 61 years old. There are 5 older executives and no younger executives at Seagen. The oldest executive at Seagen is Dr. Roger D. Dansey M.D., Chief Medical Officer and President of Research & Development, who is 67 years old. Learn More on David R. Epstein's age.
What is David R. Epstein's salary?
As the CEO of Seagen Inc., Mr. Epstein earns $1,390,000.00 per year. The highest earning executive at Seagen is Dr. Roger D. Dansey M.D., Chief Medical Officer and President of Research & Development, who commands a salary of $2,480,000.00 per year. Learn More on David R. Epstein's salary.
How do I contact David R. Epstein?
Has David R. Epstein been buying or selling shares of Seagen?
David R. Epstein has not been actively trading shares of Seagen in the last ninety days. Most recently, David R. Epstein sold 10,620 shares of the business's stock in a transaction on Friday, November 10th. The shares were sold at an average price of $213.01, for a transaction totalling $2,262,166.20. Following the completion of the sale, the chief executive officer now directly owns 136,598 shares of the company's stock, valued at $29,096,739.98. Learn More on David R. Epstein's trading history.
Who are Seagen's active insiders?
Are insiders buying or selling shares of Seagen?
In the last twelve months, insiders at the biotechnology company sold shares 20 times. They sold a total of 70,520 shares worth more than $14,429,678.66. The most recent insider tranaction occured on November, 10th when CEO David R Epstein sold 10,620 shares worth more than $2,262,166.20. Insiders at Seagen own 25.9% of the company.
Learn More about insider trades at Seagen. Information on this page was last updated on 11/10/2023.
